ArticleScientific reports2026
Low power reprogrammable DNA basecaller with an efficient HMM accelerator for real time nanopore sequencing.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Basecalling is a crucial step in DNA sequencing that converts raw nanopore signals into nucleotide sequences. This paper presents a serial-parallel reprogrammable DNA sequencing accelerator based on a 64-state Hidden Markov Model (HMM) implemented in a 130-nm CMOS process. The proposed method optimizes computational efficiency, hardware utilization, and power consumption using a coarse-grained serial-parallel processing approach. It achieves 94.3% accuracy, outperforming Nanocall (85.6%) and Meta-Align (91.2%), while being slightly superior to the Scalable Hardware Accelerator (93.1%). Furthermore, it consumes 200 mW, which is 6 times lower than brute-force HMM implementations and 3–5 times more power-efficient than deep learning-based basecallers like DeepNano and Bonito. The proposed accelerator maintains competitive throughput at 8 M Bases/sec, balancing processing speed and energy efficiency. Additionally, the architecture supports scalability up to 4096 states, making it highly adaptable for various sequencing applications. It’s hardware-optimized and low-power design makes it an ideal alternative to brute-force and software-based methods for real-time, mobile, and embedded DNA sequencing devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.